查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1574058

次世代定序的全球市場:2024-2034年

Next Generation Sequencing Market Report 2024-2034
出版日期: | 出版商: Visiongain | 英文 301 Pages | 商品交期: 最快1-2個工作天內

價格

預計到 2034 年，全球下一代定序市場規模將以 19.9% 的複合年增長率成長。

研究和臨床合作部門可望加強 NGS 市場

研究和臨床合作預計將在擴大次世代定序 (NGS) 市場方面發揮關鍵作用。這些合作可以促進創新、降低成本並擴大 NGS 技術的應用。臨床合作匯集了來自基因組學、生物資訊學、臨床醫學和數據科學等各領域的專家，以促進跨學科創新。在NGS產業，越來越多的公司正在與主要診斷和製藥公司合作，這是加速NGS在臨床環境和個人化醫療中使用的重要一步。

價格壓力是市場成長的主要障礙

價格壓力是次世代定序（NGS）領域全球擴張的主要阻礙因素。主要NGS供應商之間的激烈競爭導致了價格戰並擠壓了公司的利潤。新創公司和替代定序技術（例如奈米孔定序）正在進一步加劇競爭，迫使現有企業降低價格以保持競爭力。由於生物製藥公司對投資新藥發現持謹慎態度，全球臨床研究市場目前成長緩慢。價格壓力正在增加仿製藥的使用，並可能減緩研發投資的成長。隨著處方變得更容易取得，仿製藥的使用在世界各地迅速增加。預計這將對臨床研究行業的擴張產生負面影響，並影響 NGS 市場。

本報告提供全球次世代定序的市場調查，彙整市場概要，影響市場成長因素及市場機會分析，市場規模的轉變·預測，各種區分·地區/各主要國家的詳細分析，競爭情形，主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 摘要整理

第3章 市場概要

  • 主要調查結果
  • 市場動態
  • 影響分析
    • 市場推動要素
    • 阻礙市場要素
    • 市場機會
  • 供應鏈分析
  • 法律規範
  • 新興市場與大趨勢
  • 波特的五力分析
  • 大環境分析

第4章 次世代定序市場分析:各類型

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的轉變·預測
  • 消耗品
  • 生物資訊學
  • 定序服務
  • 預測序服務
  • 設備
    • 市場規模的轉變·預測:各地區
    • 市場佔有率:各地區

第5章 按次世代定序市場分析:工作流程

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的轉變·預測
  • 程式庫準備
  • 定序
  • 資料分析
    • 市場規模的轉變·預測:各地區
    • 市場佔有率:各地區

第6章 次世代定序市場分析:各用途

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的轉變·預測
  • 腫瘤
  • 生殖健康
  • 遺傳性疾病及罕見疾病
  • 消費者基因學
  • 農業基因組學·法醫學
  • 其他
    • 市場規模的轉變·預測:各地區
    • 市場佔有率:各地區

第7章 次世代定序市場分析:各終端用戶

  • 主要調查結果
  • 市場魅力指數
  • 市場規模的轉變·預測
  • 醫院·診療所
  • 學術研究機關
  • 製藥·生物科技企業
  • 其他
    • 市場規模的轉變·預測:各地區
    • 市場佔有率:各地區

第8章 次世代定序市場分析:各地區

  • 主要調查結果
  • 市場規模的轉變·預測

第9章 北美的次世代定序市場分析

第10章 歐洲的次世代定序市場分析

第11章 亞太地區的次世代定序市場分析

第12章 南美的次世代定序市場分析

第13章 中東·非洲的次世代定序市場分析

第14章 企業簡介

  • 競爭情形
  • 策略性展望
  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer Inc.
  • Eurofins Scientific
  • Tecan Group
  • Takara Bio
  • 10x Genomics
  • GenScript
  • Integrated DNA Technologies
  • Oxford Nanopore Technologies

第15章 總論·建議

  • Visiongain的總論
  • 市場參與企業的建議
Product Code: PHA1355

The global Next Generation Sequencing Market is projected to grow at a CAGR of 19.9% by 2034

The Next Generation Sequencing Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Research and Clinical Collaborations are Expected to Enhance the NGS Market

Research and clinical collaborations are likely to play a significant role in augmenting the next generation sequencing (NGS) market. These collaborations can drive innovation, reduce costs, and expand the application of NGS technologies. Collaborations bring together experts from various fields, such as genomics, bioinformatics, clinical medicine, and data science, fostering interdisciplinary innovation. A rising number of NGS industry players are developing partnerships with major diagnostics and pharmaceutical businesses, which is a key step towards furthering the use of NGS in clinical settings and personalised medicine. For instance, on 5th January 2024, Illumina Inc., a global pioneer in DNA sequencing and array-based technologies, said that it has entered into a collaboration with Janssen Research & Development, LLC. This will be the first cooperation to create Illumina, Inc. revolutionary molecular residual disease assay, a WGS (whole-genome sequencing) multi-cancer research service that can detect circulating tumour DNA (ctDNA) to better understand disease persistence or recurrence following clinical intervention.

Pricing Pressure has Emerged as a Significant Barrier to the Growth of the Next-Generation Sequencing Market.

Pricing pressure is a significant restraint on the global expansion of the next generation sequencing (NGS) sector. Intense rivalry among prominent NGS providers has caused price wars, which can pressure corporate margins. Emerging companies and alternative sequencing technologies (e.g., nanopore sequencing) further increase competition, forcing existing players to lower prices to remain competitive. Since biopharmaceutical companies are cautious to invest in the discovery of novel drugs, the global clinical research market is currently seeing slow growth. Price pressure is increasing the use of generic medications, which is likely to slow R&D investment growth. Due to easy access to prescriptions, the usage of generic drugs is rapidly increasing over the world. This is projected to have a negative impact on clinical research industry expansion, affecting the NGS market.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the next generation sequencing market evolving?
  • What is driving and restraining the next generation sequencing market?
  • How will each next generation sequencing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each next generation sequencing submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading next generation sequencing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the next generation sequencing projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of next generation sequencing projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the next generation sequencing manufacturing market?
  • Where is the next generation sequencing market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the next generation sequencing market today, and over the next 10 years:

  • Our 301-page report provides 118 tables and 185 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
  • Forecasts to 2034 and other analyses reveal commercial prospects
  • In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising vaccine contract manufacturing prices and recent developments.

Segments Covered in the Report

  • Type
  • Consumables
  • Bioinformatics
  • Sequencing Services
  • Whole Exome Sequencing
  • Targeted Panels
  • Whole-genome Sequencing
  • Others
  • Pre-sequencing Services
  • Library Preparation and Target Enrichment
  • Quality Control
  • Instruments
  • Workflow
  • Library Preparation
  • Semi-automated
  • Automated
  • Sequencing
  • Data Analysis
  • NGS Primary Data Analysis
  • NGS Secondary Data Analysis
  • NGS Tertiary Data Analysis
  • Application
  • Oncology
  • Diagnostics and Screening
  • Research Studies
  • Reproductive Health
  • NIPT (Noninvasive Prenatal Testing)
  • PGT (Preimplantation Genetic Testing)
  • Newborn Genetic Screening
  • Single Gene Analysis
  • Genetic and Rare Diseases
  • Consumer Genomics
  • Agrigenomics & Forensics
  • Others
  • End-use
  • Hospitals and Clinics
  • Academic and Research Institutes
  • Pharmaceutical and Biotech Companies
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Denmark
  • Norway
  • Sweden
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Thailand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America
  • MEA
  • GCC
  • South Africa
  • Turkey
  • Rest of MEA

The report also includes profiles for some of the leading companies in the Next Generation Sequencing Market, 2024 to 2034, with a focus on this segment of these companies' operations.

  • Leading companies and the potential for market growth
  • Illumina, Inc.
  • F. Hoffman-La Roche Ltd.
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Eurofins Scientific
  • Agilent Technologies
  • Tecan Group
  • Takara Bio
  • 10x Genomics
  • GenScript
  • Integrated DNA Technologies
  • Oxford Nanopore Technologies

Overall world revenue for Next Generation Sequencing Market, 2024 to 2034 in terms of value the market will surpass US$8.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034.Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

  • How will the Next Generation Sequencing Market, 2024 to 2034 report help you?
  • In summary, our 300+ page report provides you with the following knowledge:
  • Revenue forecasts to 2034 for Next Generation Sequencing Market 2024 to 2034, with forecasts for type, workflow, application, and end-use, each forecast at a global and regional level - discover the industrys' prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2034 for five regional and 20 key national markets - See forecasts for the Next Generation Sequencing Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Colombia, Germany, France, UK, Italy, Spain, Denmark, Norway, Sweden, China, India, Japan, Singapore, South Korea, Thailand, GCC Countries, South Africa, Turkey, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 14 of the major companies involved in the Next Generation Sequencing Market, 2024 to 2034.
  • Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
  • Information found nowhere else
  • With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Next Generation Sequencing Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Next Generation Sequencing Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
  • 3.3 Impact Analysis
    • 3.3.1 Market Driving Factors
      • 3.3.1.1 Rapid Technological Advancements is Boosting the NGS Market to Grow
      • 3.3.1.2 Research and Clinical Collaborations is Likely to Augment the NGS market
      • 3.3.1.3 Increasing Healthcare Spending
      • 3.3.1.4 Growing Disease Variation and Prevalence is Contributing to the Growing NGS Technology Demand
    • 3.3.2 Market Restraining Factors
      • 3.3.2.1 Lack of Skilled Professionals is Hampering the Market Growth
      • 3.3.2.2 Pricing Pressure Becomes one of the Main Obstacles to the Expansion of the Global Next Generation Sequencing
      • 3.3.2.3 Privacy and Ethical Challenges
    • 3.3.3 Market Opportunities
      • 3.3.3.1 Personalised Medicine and Precision Oncology Creates a Huge Opportunity for the Market to Grow
      • 3.3.3.2 Adoption of NGS in Biomarker Discovery and Drug Development as NGS have Accelerated the Development of Targeted Therapies
  • 3.4 Supply Chain Analysis
  • 3.5 Regulatory Framework
  • 3.6 Emerging Markets and Megatrends
  • 3.7 Porter's Five Forces Analysis
    • 3.7.1 Bargaining Power of Suppliers
    • 3.7.2 Bargaining Power of Buyers
    • 3.7.3 Competitive Rivalry
    • 3.7.4 Threat of Substitutes
    • 3.7.5 Threat of New Entrants
  • 3.8 PESTLE Analysis

4 Next Generation Sequencing Market Analysis by Type

  • 4.1 Key Findings
  • 4.2 Type Segment: Market Attractiveness Index
    • 4.2.1 Next Generation Sequencing Market Size Estimation and Forecast by Type
  • 4.3 Consumables
    • 4.3.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.3.2 Market Share by Region, 2024 & 2034 (%)
  • 4.4 Bioinformatics
    • 4.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Sequencing Services
    • 4.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6 Pre-Sequencing Services
    • 4.6.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7 Instruments
    • 4.7.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 4.7.2 Market Share by Region, 2024 & 2034 (%)

5 Next Generation Sequencing Market Analysis by Workflow

  • 5.1 Key Findings
  • 5.2 Workflow Segment: Market Attractiveness Index
    • 5.2.1 Next Generation Sequencing Market Size Estimation and Forecast by Workflow
  • 5.3 Library preparation
    • 5.3.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.3.2 Market Share by Region, 2024 & 2034 (%)
  • 5.4 Sequencing
    • 5.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Data Analysis
    • 5.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)

6 Next Generation Sequencing Market Analysis by Application

  • 6.1 Key Findings
  • 6.2 Application Segment: Market Attractiveness Index
    • 6.2.1 Next Generation Sequencing Market Size Estimation and Forecast by Application
  • 6.3 Oncology
    • 6.3.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.3.2 Market Share by Region, 2024 & 2034 (%)
  • 6.4 Reproductive Health
    • 6.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.4.2 Market Share by Region, 2024 & 2034 (%)
  • 6.5 Genetic and Rare Diseases
    • 6.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.5.2 Market Share by Region, 2024 & 2034 (%)
  • 6.6 Consumer Genomics
    • 6.6.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.6.2 Market Share by Region, 2024 & 2034 (%)
  • 6.7 Agrigenomics & Forensics
    • 6.7.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.7.2 Market Share by Region, 2024 & 2034 (%)
  • 6.8 Others
    • 6.8.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 6.8.2 Market Share by Region, 2024 & 2034 (%)

7 Next Generation Sequencing Market Analysis by End-use

  • 7.1 Key Findings
  • 7.2 End-use Segment: Market Attractiveness Index
    • 7.2.1 Next Generation Sequencing Market Size Estimation and Forecast by End-use
  • 7.3 Hospitals and Clinics
    • 7.3.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 7.3.2 Market Share by Region, 2024 & 2034 (%)
  • 7.4 Academic and Research Institutes
    • 7.4.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 7.4.2 Market Share by Region, 2024 & 2034 (%)
  • 7.5 Pharmaceutical and Biotech Companies
    • 7.5.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 7.5.2 Market Share by Region, 2024 & 2034 (%)
  • 7.6 Others
    • 7.6.1 Market Size by Region, 2024-2034 (US$ Billion)
    • 7.6.2 Market Share by Region, 2024 & 2034 (%)

8 Next Generation Sequencing Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America Next Generation Sequencing Market Analysis

  • 9.1 Key Findings
  • 9.2 North America Next Generation Sequencing Market Attractiveness Index
  • 9.3 North America Next Generation Sequencing Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 9.4 North America Next Generation Sequencing Market Size Estimation and Forecast by Country
  • 9.5 North America Next Generation Sequencing Market Size Estimation and Forecast by Type
  • 9.6 North America Next Generation Sequencing Market Size Estimation and Forecast by Workflow
  • 9.7 North America Next Generation Sequencing Market Size Estimation and Forecast by Application
  • 9.8 North America Next Generation Sequencing Market Size Estimation and Forecast by End-use
  • 9.9 U.S. Next Generation Sequencing Market Analysis
  • 9.10 Canada Next Generation Sequencing Market Analysis

10 Europe Next Generation Sequencing Market Analysis

  • 10.1 Key Findings
  • 10.2 Europe Next Generation Sequencing Market Attractiveness Index
  • 10.3 Europe Next Generation Sequencing Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 10.4 Europe Next Generation Sequencing Market Size Estimation and Forecast by Country
  • 10.5 Europe Next Generation Sequencing Market Size Estimation and Forecast by Type
  • 10.6 Europe Next Generation Sequencing Market Size Estimation and Forecast by Workflow
  • 10.7 Europe Next Generation Sequencing Market Size Estimation and Forecast by Application
  • 10.8 Europe Next Generation Sequencing Market Size Estimation and Forecast by End-use
  • 10.9 Germany Next Generation Sequencing Market Analysis
  • 10.10 France Next Generation Sequencing Market Analysis
  • 10.11 UK Next Generation Sequencing Market Analysis
  • 10.12 Italy Next Generation Sequencing Market Analysis
  • 10.13 Spain Next Generation Sequencing Market Analysis
  • 10.14 Russia Next Generation Sequencing Market Analysis
  • 10.15 Denmark Next Generation Sequencing Market Analysis
  • 10.16 Sweden Next Generation Sequencing Market Analysis
  • 10.17 Norway Next Generation Sequencing Market Analysis
  • 10.18 Rest of Europe Next Generation Sequencing Market Analysis

11 Asia Pacific Next Generation Sequencing Market Analysis

  • 11.1 Key Findings
  • 11.2 Asia Pacific Next Generation Sequencing Market Attractiveness Index
  • 11.3 Asia Pacific Next Generation Sequencing Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 11.4 Asia Pacific Next Generation Sequencing Market Size Estimation and Forecast by Country
  • 11.5 Asia Pacific Next Generation Sequencing Market Size Estimation and Forecast by Type
  • 11.6 Asia Pacific Next Generation Sequencing Market Size Estimation and Forecast by Workflow
  • 11.7 Asia Pacific Next Generation Sequencing Market Size Estimation and Forecast by Application
  • 11.8 Asia Pacific Next Generation Sequencing Market Size Estimation and Forecast by End-use
  • 11.9 Japan Next Generation Sequencing Market Analysis
  • 11.10 China Next Generation Sequencing Market Analysis
  • 11.11 India Next Generation Sequencing Market Analysis
  • 11.12 Australia Next Generation Sequencing Market Analysis
  • 11.13 South Korea Next Generation Sequencing Market Analysis
  • 11.14 Singapore Next Generation Sequencing Market Analysis
  • 11.15 Thailand Next Generation Sequencing Market Analysis
  • 11.16 Rest of Asia Pacific Next Generation Sequencing Market Analysis

12 Latin America Next Generation Sequencing Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America Next Generation Sequencing Market Attractiveness Index
  • 12.3 Latin America Next Generation Sequencing Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 12.4 Latin America Next Generation Sequencing Market Size Estimation and Forecast by Country
  • 12.5 Latin America Next Generation Sequencing Market Size Estimation and Forecast by Type
  • 12.6 Latin America Next Generation Sequencing Market Size Estimation and Forecast by Workflow
  • 12.7 Latin America Next Generation Sequencing Market Size Estimation and Forecast by Application
  • 12.8 Latin America Next Generation Sequencing Market Size Estimation and Forecast by End-use
  • 12.9 Brazil Next Generation Sequencing Market Analysis
  • 12.10 Mexico Next Generation Sequencing Market Analysis
  • 12.11 Argentina Next Generation Sequencing Market Analysis
  • 12.12 Colombia Next Generation Sequencing Market Analysis
  • 12.13 Rest of Latin America Next Generation Sequencing Market Analysis

13 MEA Next Generation Sequencing Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA Next Generation Sequencing Market Attractiveness Index
  • 13.3 MEA Next Generation Sequencing Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 13.4 MEA Next Generation Sequencing Market Size Estimation and Forecast by Country
  • 13.5 MEA Next Generation Sequencing Market Size Estimation and Forecast by Type
  • 13.6 MEA Next Generation Sequencing Market Size Estimation and Forecast by Workflow
  • 13.7 MEA Next Generation Sequencing Market Size Estimation and Forecast by Application
  • 13.8 MEA Next Generation Sequencing Market Size Estimation and Forecast by End-use
  • 13.9 GCC Countries Next Generation Sequencing Market Analysis
  • 13.10 South Africa Next Generation Sequencing Market Analysis
  • 13.11 Turkey Next Generation Sequencing Market Analysis
  • 13.12 Rest of MEA Next Generation Sequencing Market Analysis

14 Company Profiles

  • 14.1 Competitive Landscape, 2023
  • 14.2 Strategic Outlook
  • 14.3 Illumina, Inc.
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
      • 14.3.3.1 Net Revenue, 2019-2023
      • 14.3.3.2 R&D, 2019-2023
      • 14.3.3.3 Business Segment Market Shares, 2023
      • 14.3.3.4 Regional Market Shares, 2023
    • 14.3.4 Product Benchmarking
    • 14.3.5 Strategic Outlook
    • 14.3.6 SWOT Analysis
  • 14.4 F. Hoffmann-La Roche Ltd.
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Financial Analysis
      • 14.4.3.1 Net Revenue, 2019-2023
      • 14.4.3.2 R&D, 2019-2023
      • 14.4.3.3 Business Segment Market Shares, 2023
    • 14.4.4 Product Benchmarking
    • 14.4.5 Strategic Outlook
    • 14.4.6 SWOT Analysis
  • 14.5 QIAGEN
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Financial Analysis
      • 14.5.3.1 Net Revenue, 2019-2023
      • 14.5.3.2 Business Segment Market Shares, 2023
      • 14.5.3.3 Regional Market Shares, 2023
    • 14.5.4 Product Benchmarking
    • 14.5.5 Strategic Outlook
    • 14.5.6 SWOT Analysis
  • 14.6 Thermo Fisher Scientific Inc.
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Financial Analysis
      • 14.6.3.1 Net Revenue, 2019-2023
      • 14.6.3.2 Business Segment Market Shares, 2023
      • 14.6.3.3 Regional Market Shares, 2023
    • 14.6.4 Product Benchmarking
    • 14.6.5 Strategic Outlook
    • 14.6.6 SWOT Analysis
  • 14.7 Bio-Rad Laboratories, Inc.
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Financial Analysis
      • 14.7.3.1 Net Revenue, 2019-2023
      • 14.7.3.2 Regional Market Shares, 2023
      • 14.7.3.3 Business Segment Market Shares, 2023
    • 14.7.4 Product Benchmarking
    • 14.7.5 Strategic Outlook
    • 14.7.6 SWOT Analysis
  • 14.8 PerkinElmer Inc.
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Product Benchmarking
    • 14.8.4 Strategic Outlook
    • 14.8.5 SWOT Analysis
  • 14.9 Eurofins Scientific
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Financial Analysis
      • 14.9.3.1 Net Revenue, 2019-2023
      • 14.9.3.2 Regional Market Shares, 2023
      • 14.9.3.3 Business Segment Market Shares, 2023
    • 14.9.4 Product Benchmarking
    • 14.9.5 Strategic Outlook
    • 14.9.6 SWOT Analysis
  • 14.10 Tecan Group
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Financial Analysis
      • 14.10.3.1 Net Revenue, 2019-2023
      • 14.10.3.2 Regional Market Shares, 2023
      • 14.10.3.3 Business Segment Market Shares, 2023
    • 14.10.4 Product Benchmarking
    • 14.10.5 Strategic Outlook
  • 14.11 Takara Bio
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Financial Analysis
      • 14.11.3.1 Net Revenue, 2019-2023
      • 14.11.3.2 R&D, 2019-2023
      • 14.11.3.3 Regional Market Shares, 2023
      • 14.11.3.4 Business Segment Market Shares, 2023
    • 14.11.4 Product Benchmarking
    • 14.11.5 Strategic Outlook
  • 14.12 10x Genomics
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Financial Analysis
      • 14.12.3.1 Net Revenue, 2019-2023
      • 14.12.3.2 Business Segment Market Shares, 2023
      • 14.12.3.3 Region Market Shares, 2023
    • 14.12.4 Product Benchmarking
    • 14.12.5 Strategic Outlook
  • 14.13 GenScript
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Financial Analysis
      • 14.13.3.1 Net Revenue, 2019-2023
    • 14.13.4 Product Benchmarking
    • 14.13.5 Strategic Outlook
  • 14.14 Integrated DNA Technologies
    • 14.14.1 Company Snapshot
    • 14.14.2 Company Overview
    • 14.14.3 Product Benchmarking
    • 14.14.4 Strategic Outlook
  • 14.15 Oxford Nanopore Technologies
    • 14.15.1 Company Snapshot
    • 14.15.2 Company Overview
    • 14.15.3 Financial Analysis
      • 14.15.3.1 Net Revenue, 2019-2023
    • 14.15.4 Product Benchmarking
    • 14.15.5 Strategic Outlook

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks from Visiongain
  • 15.2 Recommendations for Market Players

List of Tables

  • Table 1 Next Generation Sequencing Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
  • Table 2 Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 3 Consumables Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 4 Bioinformatics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 5 Sequencing Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 6 Pre-Sequencing Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 7 Instruments Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 8 Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 9 Library Preparation Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 10 Sequencing Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 11 Data Analysis Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 12 Next Generation Sequencing Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 13 Oncology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 14 Reproductive Health Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 15 Genetic and Rare Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 16 Consumer Genomics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 17 Agrigenomics & Forensics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 18 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 19 Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 20 Hospitals and Clinics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 21 Academic and Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 22 Pharmaceutical and Biotech Companies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 23 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 24 Next Generation Sequencing Market Forecast by Region, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 25 North America Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 26 North America Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 27 North America Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 28 North America Next Generation Sequencing Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 29 North America Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 30 U.S. Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 31 Canada Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 32 Europe Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 33 Europe Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 34 Europe Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 35 Europe Next Generation Sequencing Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 36 Europe Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 37 Germany Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 38 France Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 39 UK Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 40 Italy Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 41 Spain Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 42 Russia Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 43 Denmark Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 44 Sweden Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 45 Norway Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 46 Rest of Europe Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 47 Asia Pacific Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 48 Asia Pacific Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 49 Asia Pacific Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 50 Asia Pacific Next Generation Sequencing Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 51 Asia Pacific Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 52 Japan Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 53 China Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 54 India Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 55 Australia Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 56 South Korea Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 57 Singapore Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 58 Thailand Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 59 Rest of Asia Pacific Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 60 Latin America Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 61 Latin America Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 62 Latin America Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 63 Latin America Next Generation Sequencing Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 64 Latin America Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 65 Brazil Pacific Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 66 Mexico Pacific Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 67 Argentina Pacific Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 68 Colombia Pacific Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 69 Rest of Latin America Pacific Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 70 MEA Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 71 MEA Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 72 MEA Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 73 MEA Next Generation Sequencing Market Forecast by Application, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 74 MEA Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 75 GCC Countries Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 76 South Africa Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 77 Turkey Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 78 Rest of MEA Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %, CAGR %)
  • Table 79 Strategic Outlook
  • Table 80 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 81 Illumina Inc.: Product Benchmarking
  • Table 82 Illumina Inc.: Strategic Outlook
  • Table 83 F. Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 84 F. Hoffmann-La Roche Ltd.: Product Benchmarking
  • Table 85 F. Hoffmann-La Roche Ltd.: Strategic Outlook
  • Table 86 QIAGEN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 87 QIAGEN: Product Benchmarking
  • Table 88 QIAGEN: Strategic Outlook
  • Table 89 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 90 Thermo Fisher Scientific Inc.: Product Benchmarking
  • Table 91 Thermo Fisher Scientific Inc.: Strategic Outlook
  • Table 92 Bio-Rad Laboratories, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 93 Bio-Rad Laboratories, Inc.: Product Benchmarking
  • Table 94 Bio-Rad Laboratories, Inc.: Strategic Outlook
  • Table 95 PerkinElmer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 96 PerkinElmer Inc.: Product Benchmarking
  • Table 97 PerkinElmer Inc.: Strategic Outlook
  • Table 98 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 99 Eurofins Scientific: Product Benchmarking
  • Table 100 Eurofins Scientific: Strategic Outlook
  • Table 101 Tecan Group.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 Tecan Group: Product Benchmarking
  • Table 103 Tecan Group: Strategic Outlook
  • Table 104 Takara Bio: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 105 Takara Bio: Product Benchmarking
  • Table 106 Takara Bio: Strategic Outlook
  • Table 107 10x Genomics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 108 10x Genomics: Product Benchmarking
  • Table 109 10x Genomics: Strategic Outlook
  • Table 110 GenScript: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 111 GenScript: Product Benchmarking
  • Table 112 GenScript: Strategic Outlook
  • Table 113 Integrated DNA Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 114 Integrated DNA Technologies: Product Benchmarking
  • Table 115 Integrated DNA Technologies: Strategic Outlook
  • Table 116 Oxford Nanopore Technologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 117 Oxford Nanopore Technologies: Product Benchmarking
  • Table 118 Oxford Nanopore Technologies: Strategic Outlook

List of Figures

  • Figure 1 Next Generation Sequencing Market Segmentation
  • Figure 2 Next Generation Sequencing Market by Type: Market Attractiveness Index
  • Figure 3 Next Generation Sequencing Market by Workflow: Attractiveness Index by Workflow
  • Figure 4 Next Generation Sequencing Market Attractiveness Index by Application
  • Figure 5 Next Generation Sequencing Market Attractiveness Index by End-use
  • Figure 6 Next Generation Sequencing Market Attractiveness Index by Region
  • Figure 7 Next Generation Sequencing Market: Market Dynamics
  • Figure 8 Next Generation Sequencing Market: Impact Analysis
  • Figure 9 Pharma Industry: Supply Chain Analysis
  • Figure 10 Next Generation Sequencing Market: Porter's Five Forces Analysis
  • Figure 11 Next Generation Sequencing Market: PESTLE Analysis
  • Figure 12 Next Generation Sequencing Market by Type: Market Attractiveness Index
  • Figure 13 Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 14 Next Generation Sequencing Market Share Forecast by Type, 2024, 2029, 2034 (%)
  • Figure 15 Consumables Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 16 Consumables Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 17 Bioinformatics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 18 Bioinformatics Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 19 Sequencing Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 20 Sequencing Services Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 21 Pre-Sequencing Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 22 Pre-Sequencing Services Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 23 Instruments Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 24 Instruments Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 25 Next Generation Sequencing Market by Workflow: Market Attractiveness Index
  • Figure 26 Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %)
  • Figure 27 Next Generation Sequencing Market Share Forecast by Workflow, 2024, 2029, 2034 (%)
  • Figure 28 Library Preparation Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 29 Library Preparation Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 30 Sequencing Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 31 Sequencing Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 32 Data Analysis Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 33 Data Analysis Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 34 Next Generation Sequencing Market by Application: Market Attractiveness Index
  • Figure 35 Next Generation Sequencing Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 36 Next Generation Sequencing Market Share Forecast by Application, 2024, 2029, 2034 (%)
  • Figure 37 Oncology Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 38 Oncology Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 39 Reproductive Health Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 40 Reproductive Health Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 41 Genetic and Rare Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 42 Genetic and Rare Diseases Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 43 Consumer Genomics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 44 Consumer Genomics Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 45 Agrigenomics & Forensics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 46 Agrigenomics & Forensics Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 47 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 48 Others Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 49 Next Generation Sequencing Market by End-use: Market Attractiveness Index
  • Figure 50 Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %)
  • Figure 51 Next Generation Sequencing Market Share Forecast by Indication, 2024, 2029, 2034 (%)
  • Figure 52 Hospitals and Clinics Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 53 Hospitals and Clinics Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 54 Academic and Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 55 Academic and Research Institutes Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 56 Pharmaceutical and Biotech Companies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 57 Pharmaceutical and Biotech Companies Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 58 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 59 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 60 Next Generation Sequencing Market Forecast by Region 2024 and 2034 (Revenue, CAGR %)
  • Figure 61 Next Generation Sequencing Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 62 Next Generation Sequencing Market by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 63 North America Next Generation Sequencing Market Attractiveness Index
  • Figure 64 North America Next Generation Sequencing Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 65 North America Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 66 North America Next Generation Sequencing Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 67 North America Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 68 North America Next Generation Sequencing Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 69 North America Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %)
  • Figure 70 North America Next Generation Sequencing Market Share Forecast by Workflow, 2024 & 2034 (%)
  • Figure 71 North America Next Generation Sequencing Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 72 North America Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %)
  • Figure 73 North America Next Generation Sequencing Market Share Forecast by End-use, 2024 & 2034 (%)
  • Figure 74 U.S. Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 75 Canada Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 76 Europe Next Generation Sequencing Market Attractiveness Index
  • Figure 77 Europe Next Generation Sequencing Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 78 Europe Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 79 Europe Next Generation Sequencing Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 80 Europe Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 81 Europe Next Generation Sequencing Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 82 Europe Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %)
  • Figure 83 Europe Next Generation Sequencing Market Share Forecast by Workflow, 2024 & 2034 (%)
  • Figure 84 Europe Next Generation Sequencing Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 85 Europe Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %)
  • Figure 86 Europe Next Generation Sequencing Market Share Forecast by End-use, 2024 & 2034 (%)
  • Figure 87 Germany Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 88 France Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 89 UK Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 90 Italy Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 91 Spain Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 92 Russia Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 93 Denmark Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 94 Sweden Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 95 Norway Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 96 Rest of Europe Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 97 Asia Pacific Next Generation Sequencing Market Attractiveness Index
  • Figure 98 Asia Pacific Next Generation Sequencing Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 99 Asia Pacific Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 100 Asia Pacific Next Generation Sequencing Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 101 Asia Pacific Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 102 Asia Pacific Next Generation Sequencing Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 103 Asia Pacific Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %)
  • Figure 104 Asia Pacific Next Generation Sequencing Market Share Forecast by Workflow, 2024 & 2034 (%)
  • Figure 105 Asia Pacific Next Generation Sequencing Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 106 Asia Pacific Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %)
  • Figure 107 Asia Pacific Next Generation Sequencing Market Share Forecast by End-use, 2024 & 2034 (%)
  • Figure 108 Japan Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 109 China Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 110 India Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 111 Australia Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 112 South Korea Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 113 Singapore Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 114 Thailand Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 115 Rest of Asia Pacific Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 116 Latin America Next Generation Sequencing Market Attractiveness Index
  • Figure 117 Latin America Next Generation Sequencing Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 118 Latin America Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 119 Latin America Next Generation Sequencing Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 120 Latin America Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 121 Latin America Next Generation Sequencing Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 122 Latin America Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %)
  • Figure 123 Latin America Next Generation Sequencing Market Share Forecast by Workflow, 2024 & 2034 (%)
  • Figure 124 Latin America Next Generation Sequencing Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 125 Latin America Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %)
  • Figure 126 Latin America Next Generation Sequencing Market Share Forecast by End-use, 2024 & 2034 (%)
  • Figure 127 Brazil Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 128 Mexico Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 129 Argentina Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 130 Colombia Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 131 Rest of Latin America Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 132 MEA Next Generation Sequencing Market Attractiveness Index
  • Figure 133 MEA Next Generation Sequencing Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 134 MEA Next Generation Sequencing Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 135 MEA Next Generation Sequencing Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 136 MEA Next Generation Sequencing Market Forecast by Type, 2024-2034 (US$ Billion, AGR %)
  • Figure 137 MEA Next Generation Sequencing Market Share Forecast by Type, 2024 & 2034 (%)
  • Figure 138 MEA Next Generation Sequencing Market Forecast by Workflow, 2024-2034 (US$ Billion, AGR %)
  • Figure 139 MEA Next Generation Sequencing Market Share Forecast by Workflow, 2024 & 2034 (%)
  • Figure 140 MEA Next Generation Sequencing Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 141 MEA Next Generation Sequencing Market Forecast by End-use, 2024-2034 (US$ Billion, AGR %)
  • Figure 142 MEA Next Generation Sequencing Market Share Forecast by End-use, 2024 & 2034 (%)
  • Figure 143 GCC Countries Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 144 South Africa Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 145 Turkey Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 146 Rest of MEA Next Generation Sequencing Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 147 Next Generation Sequencing Market: Company Share/Ranking, 2023
  • Figure 148 Illumina, Inc.: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 149 Illumina, Inc.: R&D, 2019-2023 (US$ Million, AGR %)
  • Figure 150 Illumina, Inc.: Business Segment Market Shares, 2023
  • Figure 151 Illumina Inc: Regional Market Shares, 2023
  • Figure 152 Illumina Inc.: SWOT Analysis
  • Figure 153 Hoffmann-La Roche Ltd.: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 154 Hoffmann-La Roche Ltd.: R&D, 2019-2023 (US$ Million, AGR %)
  • Figure 155 Hoffmann-La Roche Ltd.: Business Segment Market Shares, 2023
  • Figure 156 F. Hoffmann-La Roche Ltd.: SWOT Analysis
  • Figure 157 QIAGEN: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 158 Qiagen: Business Segment Market Shares, 2023
  • Figure 159 QIAGEN: Regional Market Shares, 2023
  • Figure 160 QIAGEN: SWOT Analysis
  • Figure 161 Thermo Fisher Scientific Inc.: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 162 Thermo Fisher Scientific Inc.: Business Segment Market Shares, 2023
  • Figure 163 Thermo Fisher Scientific Inc.: Regional Market Shares, 2023
  • Figure 164 Thermo Fisher Scientific Inc.: SWOT Analysis
  • Figure 165 Bio-Rad Laboratories, Inc.: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 166 Bio-Rad Laboratories, Inc.: Regional Market Shares, 2023
  • Figure 167 Bio-Rad Laboratories, Inc.: Business Segment Market Shares, 2023
  • Figure 168 Bio-Rad Laboratories, Inc.: SWOT Analysis
  • Figure 169 PerkinElmer Inc.: SWOT Analysis
  • Figure 170 Eurofins Scientific: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 171 Eurofins Scientific: Regional Market Shares, 2023
  • Figure 172 Eurofins Scientific: Business Segment Market Shares, 2023
  • Figure 173 Eurofins Scientific: SWOT Analysis
  • Figure 174 Tecan Group: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 175 Tecan Group: Regional Market Shares, 2023
  • Figure 176 Tecan Group: Business Segment Market Shares, 2023
  • Figure 177 Takara Bio: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 178 Takara Bio: R&D, 2018-2022 (US$ Million, AGR %)
  • Figure 179 Takara Bio: Regional Market Shares, 2023
  • Figure 180 Takara Bio: Business Segment Market Shares, 2023
  • Figure 181 10x Genomics: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 182 10x Genomics: Business Segment Market Shares, 2023
  • Figure 183 10x Genomics: Region Market Shares, 2023
  • Figure 184 GenScript: Net Revenue, 2019-2023 (US$ Million, AGR %)
  • Figure 185 Oxford Nanopore: Net Revenue, 2019-2023 (US$ Million, AGR %)